These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17280783)

  • 1. A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson's disease.
    Sutherland G; Mellick G; Sue C; Chan DK; Rowe D; Silburn P; Halliday G
    Neurosci Lett; 2007 Mar; 414(2):170-3. PubMed ID: 17280783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease.
    Ross OA; Haugarvoll K; Stone JT; Heckman MG; White LR; Aasly JO; Mark Gibson J; Lynch T; Wszolek ZK; Uitti RJ; Farrer MJ
    Parkinsonism Relat Disord; 2007 Oct; 13(7):386-8. PubMed ID: 17400506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional parkin promoter polymorphism in Parkinson's disease: new data and meta-analysis.
    Chang XL; Mao XY; Li HH; Zhang JH; Li NN; Burgunder JM; Peng R; Tan EK
    J Neurol Sci; 2011 Mar; 302(1-2):68-71. PubMed ID: 21176923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
    Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM
    Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of evidence for association of a parkin promoter polymorphism with early-onset Parkinson's disease in a Chinese population.
    Taylor JM; Wu RM; Lin CH; Delatycki MB; Lockhart PJ
    Parkinsonism Relat Disord; 2009 Feb; 15(2):149-52. PubMed ID: 18387843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
    Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multidisciplinary study of patients with early-onset PD with and without parkin mutations.
    Lohmann E; Thobois S; Lesage S; Broussolle E; du Montcel ST; Ribeiro MJ; Remy P; Pelissolo A; Dubois B; Mallet L; Pollak P; Agid Y; Brice A;
    Neurology; 2009 Jan; 72(2):110-6. PubMed ID: 18987353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PITX3 polymorphism is associated with early onset Parkinson's disease.
    Bergman O; Håkansson A; Westberg L; Nordenström K; Carmine Belin A; Sydow O; Olson L; Holmberg B; Eriksson E; Nissbrandt H
    Neurobiol Aging; 2010 Jan; 31(1):114-7. PubMed ID: 18420308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association analysis of the parkin gene in patients with sporadic Parkinson's disease from a Han population of Sichuan province].
    Peng R; Chen WJ; Wu Y; Liu M; Lai XH; Zhang JH; Yuan GG; Gou YR; Li T; Wang YC
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):38-41. PubMed ID: 17285542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coding polymorphisms in the parkin gene and susceptibility to Parkinson disease.
    Lücking CB; Chesneau V; Lohmann E; Verpillat P; Dulac C; Bonnet AM; Gasparini F; Agid Y; Dürr A; Brice A
    Arch Neurol; 2003 Sep; 60(9):1253-6. PubMed ID: 12975291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New polymorphism (IVS3-20 T-->C) of the parkin gene associated with the early-onset Parkinson's disease in Chinese].
    Zou HQ; Chen B; Ma QL; Li X; Yang JF; Feng XL; Dong XM; Li YJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Jun; 21(3):219-23. PubMed ID: 15192821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case-control study of the parkin gene in early-onset Parkinson disease.
    Clark LN; Afridi S; Karlins E; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Arch Neurol; 2006 Apr; 63(4):548-52. PubMed ID: 16606767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.
    Pankratz N; Kissell DK; Pauciulo MW; Halter CA; Rudolph A; Pfeiffer RF; Marder KS; Foroud T; Nichols WC;
    Neurology; 2009 Jul; 73(4):279-86. PubMed ID: 19636047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease.
    Sinha R; Racette B; Perlmutter JS; Parsian A
    Parkinsonism Relat Disord; 2005 Sep; 11(6):341-7. PubMed ID: 16019250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.
    Ghione I; Di Fonzo A; Saladino F; Del Bo R; Bresolin N; Comi GP; Rango M
    Neurotoxicology; 2007 May; 28(3):698-701. PubMed ID: 17335904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation screening and association analysis of the parkin gene in Parkinson's disease patients from South-West China.
    Peng R; Gou Y; Yuan Q; Li T; Latsoudis H; Yuan G; Luo D; Liu X; Collier DA
    Eur Neurol; 2003; 49(2):85-9. PubMed ID: 12584415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations.
    Wiley J; Lynch T; Lincoln S; Skipper L; Hulihan M; Gosal D; Bisceglio G; Kachergus J; Hardy J; Farrer MJ
    Mov Disord; 2004 Jun; 19(6):677-81. PubMed ID: 15197707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.